Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|February 25, 2005
Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniaeAlexey Ruzin, Melissa A Visalli, David Keeney, et al.
Diagnostic Microbiology and Infectious Disease|March 7, 1998
Synergistic activity of trovafloxacin with other agents against gram-positive and -negative organismsM A Visalli, S Bajaksouzian, M R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1996
Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methodsS Bajaksouzian, M A Visalli, M R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1997
Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studiesS Bajaksouzian, M A Visalli, M R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilisMelissa A Visalli, Ellen Murphy, Steven J Projan, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1997
Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rodsM A Visalli, S Bajaksouzian, M R Jacobs, et al.
Virology|February 3, 2019
Identification of the Epstein Barr Virus portalRobert J Visalli, Adam M Schwartz, Shivam Patel, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1995
Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococciG A Pankuch, M A Visalli, M R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|April 29, 1998
Activities and time-kill studies of selected penicillins, beta-lactamase inhibitor combinations, and glycopeptides against Enterococcus faecalisD B Hoellman, M A Visalli, M R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agentsG A Pankuch, M A Visalli, M R Jacobs, et al.
Pageof 4